Price movement over the last 24 hours
Global X Artificial Intelligence & Technology ETF vs Novavax Inc — how do they compare? Global X Artificial Intelligence & Technology ETF trades at $62.57, while Novavax Inc trades at $9.3 (market cap $1.56B). Which is the better fit depends on your goals.
| AIQ | NVAX | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $70.14 | $11.19 |
52-Week Low | $43.28 | $6.22 |
Market Cap | — | $1.56B |
Enterprise Value | — | $1.06B |
Trailing returns across standard periods
AIQ invests in companies that benefit from the development and utilization of artificial intelligence. It focuses on hardware, software, and data giants at the center of the AI revolution, including NVIDIA, Meta, and Broadcom.
Read more on AIQ →Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →